News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
37–72
Matches
261
Sources here
20
Companies here
10
Search results Stored financial headlines

Active search

261 matching headlines

Ticker or company: HUMMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Humana taps ex-Johns Hopkins exec as Medicaid leader

Humana has appointed James “J.P.” Holland, formerly president and CEO of Johns Hopkins Health Plans, as its new senior vice president and president of Medicaid. This strategic move, effective August 17, is part of a broader leadership transition and aims to bolster Humana's Medicaid …

HUM main company
Sharemaestro market context Trend signal active 52 weeks +31.5% HUM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Glenmark settles Humana antitrust lawsuit for $15.28 million

Glenmark Pharmaceuticals has settled antitrust lawsuits with Humana for $15.28 million, resolving claims related to generic drug pricing dating back to 2016. The company stated that the full settlement amount, including interest, has already been provided for in its financial records, indicating no significant …

HUM main company
Sharemaestro market context Trend signal active 52 weeks +31.5% HUM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

News by CNBC TV18 on TradingView, 2026-08-11 — cnbctv:35c78df51094b:0

Glenmark Pharmaceuticals' US subsidiary has agreed to a $15.28 million settlement with Humana Inc. to resolve antitrust lawsuits related to alleged price-fixing and anti-competitive conduct involving generic pharmaceutical products. Glenmark USA denies all allegations, stating the settlement is to avoid uncertainty, and the full …

HUM main company
Sharemaestro market context Trend signal active 52 weeks +31.5% HUM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Humacyte Inc (HUMA) Q2 2026 Earnings Report Preview: What To Expect

Humacyte Inc (HUMA) is scheduled to release its Q2 2026 earnings on August 12, 2026, with revenue expected at $1.12 million and an EPS of $-0.1. Analysts anticipate full-year 2026 revenue of $6.35 million and EPS of $-0.34. Despite previous revenue estimate declines, earnings …

HUMA main company
Sharemaestro market context Price below Trend Line 52 weeks -61.7% HUMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Humana Healthy Horizons in Indiana Collaborates with HealthStream to Expand and Strengthen Home Care Workforce

Certification Scholarships and Innovative Retention Program Address Critical Health Need INDIANAPOLIS, August 11, 2026--(BUSINESS WIRE)--Humana Healthy Horizons in Indiana, Humana's Medicaid managed care plan, is collaborating with HealthStream (Nasdaq: HSTM), a leading healthcare technology platform company for clinical workforce solutions, to improve the lives …

HUM main company H1UM34 main company HUM main company
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8% HUM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Humana Inc. (HUM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Humana Inc. (NYSE:HUM) for alleged corporate wrongdoing. The firm encourages investors who purchased Humana securities prior to June 27, 2022, and still hold them, to contact them to assist in the investigation. The investigation …

HUM main company
Sharemaestro market context Trend signal active 52 weeks +31.5% HUM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Humacyte, Inc. (NASDAQ:HUMA) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Eight brokerages have given Humacyte, Inc. (NASDAQ:HUMA) a consensus recommendation of "Moderate Buy," with one analyst issuing a sell rating and seven a buy rating. The average one-year price target is $6.25. Insider activity shows a sale by Shamik J. Parikh and a purchase …

HUMA main company
Sharemaestro market context Price below Trend Line 52 weeks -61.7% HUMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Humana Names James P. Holland President of Medicaid

Humana Inc. (NYSE: HUM) has appointed James "J.P." Holland as Senior Vice President and President of Medicaid, effective August 17. Holland will lead Humana's Medicaid business, which serves over 1.6 million members across 11 states, reporting to Aaron Martin, President of Insurance. He brings …

HUM main company
Sharemaestro market context Trend signal active 52 weeks +31.5% HUM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Humana’s Incoming Medicaid President Will Lead Business in 11 States

Humana Inc. announced that James “J.P.” Holland will join the company as Senior Vice President and President of Medicaid, effective August 17. In this role, Holland will lead Humana's Medicaid business, which currently serves over 1.6 million members across 11 states. He brings extensive …

HUM main company
Sharemaestro market context Trend signal active 52 weeks +31.5% HUM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

James P. Holland to Join Humana as Medicaid President

LOUISVILLE, Ky., August 10, 2026--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced that James "J.P." Holland will join the company as senior vice president and President of Medicaid, effective August 17. In this role, Holland will lead the company's growing Medicaid business, which currently serves …

HUM main company H1UM34 main company HUM main company
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8% HUM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Humacyte Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humacyte, Inc. - HUMA

Kahn Swick & Foti, LLC (KSF) is continuing its investigation into Humacyte, Inc. regarding potential breaches of fiduciary duties by its officers and directors and violations of state or federal laws. This follows an FDA Form 483 inspection revealing violations at Humacyte's Durham facility …

HUMA main company
Sharemaestro market context Price below Trend Line 52 weeks -61.7% HUMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ihuman Inc (IH) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Ihuman Inc (IH), including future EPS and revenue growth estimates. It lists current stock information such as market cap and P/E ratio, along with a peer comparison of other software and IT services companies and their analyst …

IH main company
Sharemaestro market context Price below Trend Line 52 weeks -48.6% · Next-week setup negative 40.6% IH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Humana Inc. (HUM) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of Humana Inc. (NYSE:HUM) shareholders who purchased securities before June 27, 2022, and continue to hold them. The investigation focuses on whether Humana's officers and/or directors engaged in corporate wrongdoing. The firm encourages …

HUM main company
Sharemaestro market context Trend signal active 52 weeks +31.5% HUM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Humana Inc. $HUM Stock Position Decreased by Gradient Investments LLC

Gradient Investments LLC reduced its stake in Humana Inc. by 31.3% in the second quarter, selling 6,112 shares and retaining 13,408 shares valued at $5.33 million. Despite this, other institutional investors have increased their positions. Humana reported strong quarterly earnings, beating estimates with $7.61 …

HUM main company
Sharemaestro market context Trend signal active 52 weeks +31.5% HUM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

180 Wealth Advisors LLC Cuts Stake in Humana Inc. $HUM

180 Wealth Advisors LLC significantly reduced its stake in Humana Inc. (NYSE:HUM) by 83.1% in the second quarter, selling 3,237 shares and retaining 656 shares valued at $260,000. Despite this, other institutional investors increased their positions, and Humana reported strong quarterly earnings of $7.61 …

HUM main company
Sharemaestro market context Trend signal active 52 weeks +31.5% HUM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Humana Inc. (HUM) Stock forecasts

This article provides a brief stock forecast for Humana Inc. (HUM), noting a bullish technical assessment in the intermediate term according to Argus as of August 4, 2026. It also mentions a heavy earnings week for the IT sector, listing several companies scheduled to …

HUM main company
Sharemaestro market context Trend signal active 52 weeks +31.5% HUM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Humana (HUM) Is Up 5.8% After Cutting 2026 EPS Outlook Amid Strong Q2 And Buybacks

In late July 2026, Humana reported higher second-quarter revenue of US$40,867 million and net income of US$694 million, while also confirming completion of a US$276.13 million share repurchase program initiated in February 2024 and announcing two new board appointments, Paul Smith and Frederick Crawford. …

HUM main company H1UM34 main company HUM main company
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8% HUM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Humana Inc. stock outperforms competitors on strong trading day

Humana Inc. (HUM) shares rose by 4.84% to $385.00 on Friday, marking its third consecutive day of gains. This performance outpaced the broader market, with the S&P 500 Index (SPX) increasing by 0.62% and the Dow Jones Industrial Average (DJIA) rising by 0.28%. The …

HUM main company
Sharemaestro market context Trend signal active 52 weeks +31.5% HUM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Humacyte To Announce 2026 Second Quarter Financial Results and Provide Business Update on August 12, 2026

Humacyte, Inc. (Nasdaq: HUMA) announced it will release its financial results for the second quarter and six months ended June 30, 2026, on Wednesday, August 12, 2026. The company will host a webcast and conference call at 8:00 a.m. Eastern Time to provide a …

HUMA main company
Sharemaestro market context Price below Trend Line 52 weeks -61.7% HUMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ihuman Inc (IH) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Ihuman Inc (IH), detailing its current price momentum score, support and resistance levels, and indicator and moving average readings. It notes that IH is currently suitable for range-bound swing trading, with a resistance at 1.43 and support …

IH main company
Sharemaestro market context Price below Trend Line 52 weeks -48.6% · Next-week setup negative 40.6% IH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ANTITRUST—E.D. Pa.: Humana’s generic-drug price-fixing claims will proceed to bellwether trial

The article reports that Humana's antitrust claims alleging generic drug price-fixing will proceed to a bellwether trial in the Eastern District of Pennsylvania. This indicates a significant development in the ongoing litigation, allowing a representative case to be tried to gauge potential outcomes for …

HUM main company
Sharemaestro market context Trend signal active 52 weeks +31.5% HUM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bank of America Corp DE Decreases Holdings in Humana Inc. $HUM

Bank of America Corp DE has reduced its stake in Humana Inc. by 4.5% in the first quarter of 2026, selling 37,680 shares but still retaining 806,887 shares valued at $139.9 million. This move comes as institutional investors collectively hold a significant 92.38% of …

HUM main company
Sharemaestro market context Trend signal active 52 weeks +31.5% HUM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

iCare’s pending Wisconsin award could expand care to 7 counties

Humana subsidiary iCare has received an intent to award for Family Care and Family Care Partnership contracts in Wisconsin's greater southeast region. This expansion will allow iCare to serve all seven counties in the service area, ensuring continuity for existing members and providing access …

HUM main company
Sharemaestro market context Trend signal active 52 weeks +31.5% HUM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Humana Subsidiary iCare Selected for Family Care and Family Care Partnership Contracts Across Southeast Wisconsin

Independent Care Health Plan expands service area to all seven counties in Wisconsin's greater southeast region, ensuring continuity for existing members and new access to high-quality long-term care services LOUISVILLE, Ky., August 05, 2026--(BUSINESS WIRE)--Independent Care Health Plan (iCare), a Humana subsidiary, has been …

HUM main company H1UM34 main company HUM main company
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8% HUM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

This Humana Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday

A Morgan Stanley analyst has upgraded Humana Inc. (NYSE: HUM) from Underweight to Equal-Weight, raising the price target. This article also details four other significant analyst upgrades for Wednesday, including Kratos Defense & Security Solutions, Advanced Energy Industries, Archer-Daniels-Midland, and Knife River Corp, with …

HUM main company HUM main company
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8% HUM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Humana Community Day 2026 Mobilizes Thousands of Employees Nationwide to Support Healthier Communities

Humana announced its annual Humana Community Day 2026, scheduled for August 26, 2026, mobilizing thousands of employees across the U.S. to volunteer for community health initiatives. The event focuses on addressing local needs like food insecurity and neighborhood revitalization in partnership with non-profit organizations, …

HUM main company H1UM34 main company HUM main company
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8% HUM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context